Juan Manuel Guzman-Flores
Overview
Explore the profile of Juan Manuel Guzman-Flores including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Esquivias F, Guzman-Flores J, Pech-Santiago E, Guerrero-Barrera A, Delgadillo-Aguirre C, Anaya-Esparza L
Cell Biochem Biophys
. 2025 Feb;
PMID: 39966335
Prostate cancer (PCa) is a major cause of cancer-related mortality in men. This study explores the anticancer potential of Quercetin, a polyphenolic compound with antioxidant and anti-inflammatory properties, by network...
2.
Basaldua-Maciel V, Guzman-Flores J, Reyes-Chaparro A, Martinez-Esquivias F
Curr Top Med Chem
. 2025 Feb;
PMID: 39949091
Introduction: Currently, there are pharmacological treatments for type 2 diabetes (T2D), but these are ineffective. Quercetin is a flavonoid with antidiabetic properties. Objective: This research aimed to identify the molecular...
3.
Gonzalez-Sanchez G, Martinez-Perez L, Perez-Reyes A, Guzman-Flores J, Garcia-Robles M
Nutr Hosp
. 2024 Oct;
41(6):1194-1201.
PMID: 39446118
Background: metabolic syndrome (MetS) is a group of clinical anomalies that share an inflammatory component of multifactorial etiology. Objectives: the present study aims to relate the genetic variant (rs61330082 C/T)...
4.
Vazquez-Jimenez S, Gonzalez-Sanchez G, Guerrero-Velazquez C, Guzman-Flores J
Endocr Metab Immune Disord Drug Targets
. 2024 Sep;
PMID: 39318016
Introduction/objective: Bioinformatic analysis is a valuable tool that allows us to collect, archive, analyze, and disseminate biological data for further interpretation. Analysis of the IL-23/IL-17A axis and its receptors will...
5.
Martinez-Esquivias F, Guzman-Flores J, Reyes-Chaparro A, Sanchez-Enriquez S, Anaya-Esparza L
J Cell Biochem
. 2024 Sep;
126(1):e30655.
PMID: 39300905
This network pharmacology study represents a significant step in understanding the potential of Resveratrol as an antidiabetic agent and its molecular targets. Targets for Type 2 diabetes were obtained from...
6.
Guzman-Flores J, Perez-Reyes A, Vazquez-Jimenez S, Isiordia-Espinoza M, Martinez-Esquivias F
Dent J (Basel)
. 2024 Jun;
12(6).
PMID: 38920854
Background: Dental caries is a dynamic, multifactorial disease that destroys teeth and can affect anyone's quality of life because it can cause tooth loss and make chewing difficult. Dental caries...
7.
Gomez-Sanchez E, Hernandez-Gomez A, Guzman-Flores J, Alonso-Castro A, Serafin-Higuera N, Balderas-Pena L, et al.
Clin Pract
. 2024 Mar;
14(2):461-472.
PMID: 38525714
This systematic review and meta-analysis aimed to evaluate the analgesic efficacy and adverse effects of celecoxib after total knee arthroplasty. Keywords in the PubMed and Scopus databases were used to...
8.
Martinez-Esquivias F, Guzman-Flores J, Chavez-Diaz I, Iniguez-Munoz L, Reyes-Chaparro A
J Biomol Struct Dyn
. 2023 Sep;
42(21):11750-11761.
PMID: 37776009
Cervical cancer (CC) is the most frequent cancer in the female population worldwide. Although there are treatments available, they are ineffective and cause adverse effects. 6-gingerol is an active component...
9.
Franco-de la Torre L, Gomez-Sanchez E, Aragon-Martinez O, Hernandez-Gomez A, Franco-Gonzalez D, Guzman-Flores J, et al.
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765095
The aim of this systematic review and meta-analysis was to evaluate the analgesic effect of different doses of tapentadol immediate release (IR) and its adverse effects after a bunionectomy. Pubmed,...
10.
De la Cruz-Ahumada C, Topete-Reyes J, Mena-Ramirez J, Guzman-Flores J, Guzman-Gonzalez J, Ramirez-De Los Santos S
J Pers Med
. 2023 Sep;
13(9).
PMID: 37763079
Hemodialysis deteriorates patients' physical, metabolic, and mental status. Clinical outcomes derived from inflammation determine a worse status but are less frequently identified. The objective of the study was to identify...